Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China
- Conditions
- Stent Thrombosis
- Registration Number
- NCT03491891
- Lead Sponsor
- The First Hospital of Jilin University
- Brief Summary
The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter registries.
- Detailed Description
This study represents a patient-level pooled analysis of patients undergoing percutaneous coronary intervention with stent implantation for acute coronary syndrome. Multiple aspects including clinical, angiographic, procedural characteristics , intravascular imaging results and blood samples were collected at index PCI and the time of VLST or CAG during follow-up, in order to reveal the potential mechanisms or risk factors that contribute to the development of VLST.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8476
- Patients>18y,admitted for acute coronary syndrome,successfully underwent PCI with at least one stent, sign informed consent.
- Expected lifetime was less than 1 year for any severe disease(such as tumor,severe respiratory failure et al). There is a surgical plan for important organs within 1 year after surgery and anti-platelet drugs should be discontinued. Refusing to sign informed consent.Died prior to discharge. Poor compliance, unable to participate in regular follow-up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Very Late Stent Thrombosis Five years very late stent thrombosis demonstrated by coronary angiography
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Jilin University 1st Hospital
🇨🇳Changchun, Jilin, China